Determination of Regulatory Review Period for Purposes of Patent Extension; VANFLYTA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VANFLYTA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; VANFLYTA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VANFLYTA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; REZZAYO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for REZZAYO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; REZZAYO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for REZZAYO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; REZZAYO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for REZZAYO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; MIEBO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for MIEBO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; MIEBO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for MIEBO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; TALZENNA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for TALZENNA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; VANFLYTA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VANFLYTA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; MIEBO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for MIEBO and is publishing this notice of that determination as required by law. FDA …

Development of an Enhanced Systematic Process for the Food and Drug Administration’s Post-Market Assessment of Chemicals in Food; Public Meeting; Request for Comments

The Food and Drug Administration FDA or we is announcing the following public meeting entitled Development of an Enhanced Systematic Process for FDA's Post-Market Assessment of Chemicals in Food. This …

Determination of Regulatory Review Period for Purposes of Patent Extension; INPEFA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for INPEFA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; MIEBO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for MIEBO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; XOFLUZA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for XOFLUZA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; VANFLYTA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VANFLYTA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; VANFLYTA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VANFLYTA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; INPEFA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for INPEFA and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; MIEBO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for MIEBO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …